How much funding has Variantyx raised?

Variantyx has raised $100.0M in total funding, most recently a Series D round.

Who are Variantyx's investors?

Variantyx's investors include Kreos Capital, GHS Fund, New Era Capital Partners, Peregrine Ventures, Bosch Ventures, Pitango Growth.

Where is Variantyx headquartered?

Variantyx is headquartered in Boston, Massachusetts, United States.

What industry is Variantyx in?

Variantyx operates in Diagnostics, Genomics, Healthcare.

How many employees does Variantyx have?

Variantyx has 51-200 employees.

Variantyx

We See More In Every Genetic Test

Boston, United States · Founded 2014 · $100.0M raised

Diagnostics

Genomics

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: variantyx.com
Total Funding: $100.0M
Last Round: $36.0M Series DApr 2024
Rounds: 6

About

Variantyx is a molecular diagnostics company offering whole-genome-based genetic testing for rare genetic disorders, neurology, reproductive genetics, and precision oncology. Its Genomic Unity platform delivers comprehensive variant detection using both short-read and Oxford Nanopore long-read whole genome sequencing, serving clinicians and healthcare providers.

Summary

Variantyx is a Diagnostics company based in Boston, United States, founded in 2014. It has raised $100.0M in total across 6 rounds, most recently a $36.0M Series D round in Apr 2024. Investors include Kreos Capital, GHS Fund and New Era Capital Partners.